Santen Incorporated, a wholly owned subsidiary of Santen Pharmaceutical Co., Ltd., opened its doors in the San Francisco Bay Area in 1993. Located in Northern California’s Napa Valley, the U.S. office is comprised of established, highly experienced healthcare professionals, led by President and CEO, Adrienne Graves, PhD. On average, each member of the U.S. senior management team has 20 or more years of industry experience, with extensive knowledge and expertise based exclusively in the ophthalmic field. The leading ophthalmic pharmaceutical company in Japan since 1890, Santen specializes in treatments for eye and rheumatic diseases, offering both prescription and over-the-counter (OTC) products.
In early 2004, Santen entered into a partnership agreement with VISTAKON® Pharmaceuticals, LLC, granting VISTAKON the exclusive U.S. distribution rights to the established Santen ophthalmic products QUIXIN® (levofloxacin ophthalmic solution) 0.5%, BETIMOL® (timolol ophthalmic solution) 0.25% and 0.5%, and ALAMAST® (pemirolast potassium ophthalmic solution) 0.1%. This synergistic arrangement will enable Santen to move forward with a renewed emphasis on the discovery and development of exciting new products that will make a significant difference in eye care.
| Contact Details: |
| 555 Gateway Drive |
| Napa |
| California |
| 94558 |
| United States of America |
| Tel: | 707 254 1750 |
| Fax: | 707 254 3648 |
| Email: | info@santeninc.com |
| WWW: | www.santeninc.com/
|
|
Loading...
|
Recent Publications by Santen Incorporated: |  |
Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
PURPOSE: To understand the mechanisms of action of cyclosporin A eye drops... | 11th November, 2009
| Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16
| Curr Eye Res. 2009 Jun;34(6):426-37.
|
Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents.
We recently demonstrated that SA13353... | 3rd November, 2009
| Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16
| Eur J Pharmacol. 2009 Oct 28.
DOI Direct Link |
Ocular hypotensive effects of anti-glaucoma agents in mice.
PURPOSE: To evaluate the ocular hypotensive effects induced by topical... | 28th October, 2009
| Research and Development Center, Santen Pharmaceutical Co. Ltd., Nara,
| J Ocul Pharmacol Ther. 2009 Oct;25(5):401-8.
DOI Direct Link |
Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
PURPOSE: The effects of cyclosporine A eye drops on the early-phase... | 22nd October, 2009
| Research and Development Center, Santen Pharmaceutical Co. Ltd.,
| J Ocul Pharmacol Ther. 2009 Aug;25(4):321-8.
DOI Direct Link |
Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
The disposition and metabolism of tafluprost, an ester prodrug of the... | 20th October, 2009
| Non-clinical Research Group, Research and Development Center, Santen
| Drug Metab Dispos. 2009 Aug;37(8):1622-34. Epub 2009 May 28.
DOI Direct Link |
→View more Santen Incorporated research publications. |
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 47 individuals from Santen Incorporated using this service.
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 689 times since April 2007, the link to the organisation's website has been followed 59 times
Recent Search Terms used to find this page: Adrienne Graves 2009 santen | santen patent | SA13353 patent | SA13353 patent | SA13353 patent | .
Search for more companies in Napa
Search for more companies in California
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Santen Incorporated
